The today show just reported that Merk is halting the trial for Keytruda in lung cancer because it works so well and will now provide it to all patients in the study.
***I mention this because its exciting to think that you don't have to finish a trial to have success. We can have success much sooner than anticipated in any one of our trials like B-OM or K for Ovarian etc.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.